Human CC chemokine 2 (HCC-2) is a novel member of the chemokine peptide fam
ily that induces chemotaxis of monocytes, T lymphocytes and eosinophils via
activation of the CCR-1 and CCR-3 receptors. Fmoc chemistry was optimized
and used to synthesize the biologically active 66-residue peptide HCC-2-(48
-113). Introduction of the three disulfide bonds was achieved by oxidative
folding in the presence of the redox system cysteine/cystine. Alternatively
, a semiselective approach utilizing a mixed Acm/Trt protection scheme for
disulfide formation was applied. It was found that, without participation o
f the two HCC-2-specific cysteine residues in positions 64 and 104, the two
typical chemokine disulfides are formed predominantly during oxidative fol
ding. In addition, the mutant [Ala64,104]HCC-2-(48-113) lacking the third d
isulfide bond that discriminates HCC-2 from most other chemokines was synth
esized. For disulfide bond formation, oxidative folding was compared with t
he use of Acm/Trt protection. HCC-2-(48-113) and the mutant [Ala64,104]HCC-
2-(48-113) were further analyzed by CD and one-dimensional H-1 NMR-spectros
copy. Both peptides adopt a similar stable secondary and tertiary structure
in solution.